Boston Scientific (BSX) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Boston Scientific (BSX) PT Raised to $32 at Citi
February 5, 2018 6:27 AM ESTCiti raised its price target on Boston Scientific (NYSE: BSX) to $32.00 (from $31.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $35 at Needham & Company
February 1, 2018 3:28 PM ESTNeedham & Company raised its price target on Boston Scientific (NYSE: BSX) to $35.00 (from $32.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "BSX's 4Q17 revenue was consistent with its 1/9/18 preannouncement while its EPS met consensus. Management provided initial 2018 revenue guidance... More
Boston Scientific (BSX) PT Raised to $31 at Stifel
February 1, 2018 2:46 PM ESTStifel raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $30.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $28.50 at Evercore ISI
February 1, 2018 12:45 PM ESTEvercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $27.00) while maintaining a In Line rating.
... More